| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 0 | 0 | 5.773 | 0 | 35.043 | 134.279 | 169.754 | 200.662 |
| Total Income - EUR | - | - | 0 | 0 | 5.774 | 2 | 35.046 | 134.309 | 170.340 | 215.135 |
| Total Expenses - EUR | - | - | 51 | 436 | 3.444 | 1.467 | 12.890 | 39.797 | 66.357 | 70.271 |
| Gross Profit/Loss - EUR | - | - | -51 | -436 | 2.330 | -1.465 | 22.156 | 94.512 | 103.983 | 144.864 |
| Net Profit/Loss - EUR | - | - | -51 | -436 | 2.163 | -1.465 | 21.805 | 93.191 | 102.319 | 138.959 |
| Employees | - | - | 0 | 0 | 1 | 0 | 2 | 2 | 2 | 3 |
Check the financial reports for the company - Siromedica Group Consult Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 0 | 0 | 0 | 0 | 6.103 | 35.573 | 33.386 |
| Current Assets | - | - | 15 | 9 | 3.453 | 2.175 | 30.306 | 95.027 | 100.195 | 117.519 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 3.182 | 0 | 0 |
| Receivables | - | - | 0 | 0 | 362 | 0 | 827 | 70.669 | 33.872 | 97.257 |
| Cash | - | - | 15 | 9 | 3.091 | 2.175 | 29.478 | 21.176 | 66.323 | 20.261 |
| Shareholders Funds | - | - | -7 | -442 | 1.731 | 234 | 22.034 | 93.420 | 102.370 | 139.010 |
| Social Capital | - | - | 44 | 43 | 44 | 43 | 42 | 43 | 42 | 42 |
| Debts | - | - | 22 | 451 | 1.722 | 1.941 | 8.272 | 7.709 | 11.999 | 5.043 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 21.399 | 6.852 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Siromedica Group Consult Srl